Latest Earnings Results: Q4 '26
Estimated EPS
$2.42
Reported EPS
$2.91
Surprise
+20.01%
Estimated Rev
$64.98B
Reported Rev
$63.67B
Surprise
-2.02%
• Reported GAAP EPS of $1.70 up 68.32% YoY • Reported revenue of $63.67B up 5.84% YoY • Cardinal Health provides fiscal year 2027 non-GAAP diluted EPS guidance of 13% to 15% growth, representing a range of $12.40 to $12.60, which is above the company's long-term EPS guidance.
Bullish Takeaway
Cardinal Health delivered double-digit profit growth across all five segments, significantly expanded its share repurchase authorization, and secured a long-term distribution contract renewal with Kroger to bolster future operational performance.
Bearish Takeaway
Cardinal Health experienced a revenue decline in the Global Medical Products and Distribution segment, recognized a $122 million equity impairment, and faces ongoing risks related to tariff costs and competitive pressures.
Generated by Stocktwits using AI and company-reported earnings data for Q4 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q1 '27 | $2.93 | -- | -- | N/A |
Q4 '26 | $2.42 | $2.91 | 20.01% | BEAT |
Q3 '26 | $2.79 | $3.17 | 13.43% | BEAT |
Q2 '26 | $2.34 | $2.63 | 12.35% | BEAT |
Q1 '26 | $2.18 | $2.55 | 16.87% | BEAT |